期刊文献+

藻酸双脂钠联合非诺贝特治疗2型糖尿病合并严重高甘油三酯血症76例分析

Efficacy of alginic sodium diester plus fenofibrate in type 2 diabetes complicated with severe hypertriglyceridemia and on insulin resistance.
暂未订购
导出
摘要 2型糖尿病(T2DM)发病的中心环节是糖代谢紊乱,同时脂肪代谢也出现异常。本文通过观察联合应用藻酸双脂钠和非诺贝特治疗T2DM合并严重高甘油三酯(TG)血症患者的临床疗效,探讨其对血脂及胰岛素抵抗的影响。
作者 宋晓燕 郭剑
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第3期224-225,共2页 Chinese Journal of Practical Internal Medicine
关键词 藻酸双脂钠 非诺贝特 2型糖尿病 高甘油三酯血症 胰岛素抵抗 alginic sodium diester fenofibrate type 2 diabetes hypertriglyeeridemia insulin resistance
  • 相关文献

参考文献3

二级参考文献13

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3089
  • 2杨文英,邢小燕,林红,马晓华,胡英华,李光伟,潘孝仁.高甘油三酯血症是非胰岛素依赖型糖尿病发病的危险因素──432例非糖尿病人群六年前瞻性观察[J].中华内科杂志,1995,34(9):583-586. 被引量:143
  • 3Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens, 2007, 25(6), 1105.
  • 4[No authors listed]. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancent, 1994, 344(8934): 1383.
  • 5[No authors listed]. Prevention of cardiovascular events and death with pravastafin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.N Engl J Med, 1998, 339(19):1349.
  • 6Heart Protection Study Collaborative Group.MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randornised placebo-controlled trial. Lancet, 2002, 360(9326) : 7.
  • 7Sever PS, Dahlof B, Pouher NR, et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet, 2003, 361 (9364): 1149.
  • 8Yuan G,Al-Shali KZ,Hegele RA.Hypertriglyceridemia:its etiology,effects and treatment.CMAJ,2007,176(8):1113.
  • 9Hokanson JE,Austin MA.Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level:a meta-analysis of population-based prospective studies.J Cardiovasc Risk,1996,3(2):213.
  • 10St-Pierre J,Lemieux I,Perron P,et al.Relation of the “hypertriglyceridemic waist” phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus.Am J Cardiol,2007,99(3):369.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部